LLY

751.49

+0.07%↑

JNJ

153.95

+1.34%↑

UNH

323.91

+3.75%↑

ABBV

184.94

-0.06%↓

NVO

68.4

+2.97%↑

LLY

751.49

+0.07%↑

JNJ

153.95

+1.34%↑

UNH

323.91

+3.75%↑

ABBV

184.94

-0.06%↓

NVO

68.4

+2.97%↑

LLY

751.49

+0.07%↑

JNJ

153.95

+1.34%↑

UNH

323.91

+3.75%↑

ABBV

184.94

-0.06%↓

NVO

68.4

+2.97%↑

LLY

751.49

+0.07%↑

JNJ

153.95

+1.34%↑

UNH

323.91

+3.75%↑

ABBV

184.94

-0.06%↓

NVO

68.4

+2.97%↑

LLY

751.49

+0.07%↑

JNJ

153.95

+1.34%↑

UNH

323.91

+3.75%↑

ABBV

184.94

-0.06%↓

NVO

68.4

+2.97%↑

Search

Lantheus Holdings Inc

Ouvert

SecteurSoins de santé

76.98 -2.79

Résumé

Variation du prix de l'action

24h

Actuel

Min

76.57

Max

79.26

Chiffres clés

By Trading Economics

Revenu

85M

73M

Ventes

-18M

373M

P/E

Moyenne du Secteur

18.239

56.602

BPA

1.53

Marge bénéficiaire

19.569

Employés

808

EBITDA

93M

115M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+54.63% upside

Dividendes

By Dow Jones

Prochains Résultats

30 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2B

5.5B

Ouverture précédente

79.77

Clôture précédente

76.98

Sentiment de l'Actualité

By Acuity

21%

79%

47 / 382 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Lantheus Holdings Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 mai 2025, 20:40 UTC

Acquisitions, Fusions, Rachats

FedEx Names CEO, Chairman for Planned Freight Spinoff

20 mai 2025, 00:00 UTC

Actualités

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19 mai 2025, 23:48 UTC

Market Talk

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19 mai 2025, 23:43 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

19 mai 2025, 23:22 UTC

Actualités

Crypto Billionaire Accused of Defrauding Creditors, Propelling Industry's 2022 Collapse -- WSJ

19 mai 2025, 22:33 UTC

Market Talk

Uranium Buyers Could Accelerate Restocking -- Market Talk

19 mai 2025, 22:16 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19 mai 2025, 22:16 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell Stake for CNY4.15B

19 mai 2025, 22:15 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell Stake to China Resources Land

19 mai 2025, 22:15 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q Rev $1.9B >TCOM

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q Adj EPS 82c >TCOM

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q EPS 84c >TCOM

19 mai 2025, 21:58 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19 mai 2025, 21:58 UTC

Market Talk

Global Equities Roundup: Market Talk

19 mai 2025, 21:58 UTC

Market Talk

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19 mai 2025, 21:50 UTC

Actualités
Résultats

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 mai 2025, 20:48 UTC

Actualités

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19 mai 2025, 20:20 UTC

Actualités

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19 mai 2025, 20:15 UTC

Acquisitions, Fusions, Rachats

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19 mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19 mai 2025, 19:59 UTC

Actualités

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19 mai 2025, 19:58 UTC

Market Talk

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19 mai 2025, 19:52 UTC

Market Talk

Imports Accelerate at Southern California Ports -- Market Talk

Comparaison

Variation de prix

Lantheus Holdings Inc prévision

Objectif de Prix

By TipRanks

54.63% hausse

Prévisions sur 12 Mois

Moyen 121 USD  54.63%

Haut 137 USD

Bas 110 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

9 ratings

8

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

79.24 / 103.64Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Neutral Evidence

Sentiment

By Acuity

47 / 382Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.